Becker's Healthcare December 16, 2024
Francesca Mathewes

The rising use of GLP-1 medications, such as Novo Nordisk’s Wegovy and Ozempic, for weight loss has driven up patients’ visits to their physicians, resulting in more frequent diagnoses of other health issues, Finimize reported Dec. 16.

Here are five things to know about GLP-1s and increased healthcare utilization:

1. According to the report, an uptick in GLP-1 use is facilitating a range of “crucial preventive care,” including pap smears and colonoscopies.

2. ResMed, a producer of sleep apnea machines, reported an 11% revenue bump, partly credited to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Survey / Study, Trends
How has U.S. Spending on Health Care Changed Over Time?
Merck enters $2B licensing deal for weight loss drug
How Medicare Negotiated Drug Prices Compare to Other Countries
The Fed's Warnings On Inflation Are Bad News For Biotech Startups
AI Tech Firm SandboxAQ Adds $300M to Ramp Up Development of LQMs for Drug Discovery & More

Share This Article